LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
47 hedge funds and large institutions have $917K invested in LogicBio Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
47
Holding in Top 10
–
Calls
$8K
Puts
–
Top Buyers
| 1 | +$23K | |
| 2 | +$18K | |
| 3 | +$11.4K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.45K |
Top Sellers
| 1 | -$223K | |
| 2 | -$161K | |
| 3 | -$124K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$77.4K |
| 5 |
VF
Virtu Financial
New York
|
-$49K |